The focus of this work was to confirm the essential role of RAD18 in CRC growth and identify a key upstream regulator of RAD18, E2F7, which reduced the killing effect of NK cells in CRC by activating RAD18 transcription. This evidence concerns the gene RAD18 and colorectal carcinoma.